Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus

被引:96
作者
Bergman, Jacques J. G. H. M. [3 ]
Zhang, Yue-Ming [1 ]
He, Shun [1 ]
Weusten, Bas [3 ,4 ]
Xue, Liyan [2 ]
Fleischer, David E. [5 ]
Lu, Ning [2 ]
Dawsey, Sanford M. [6 ]
Wang, Gui-Qi [1 ]
机构
[1] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Endoscopy, Beijing 100021, Peoples R China
[2] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Pathol, Beijing 100021, Peoples R China
[3] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands
[4] St Antonius Hosp, Dept Gastroenterol & Hepatol, Nieuwegein, Netherlands
[5] Mayo Clin, Div Gastroenterol & Hepatol, Scottsdale, AZ USA
[6] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA
关键词
HIGH-GRADE DYSPLASIA; HIGH-RISK AREA; BARRETTS-ESOPHAGUS; LOCAL RECURRENCE; SUBMUCOSAL DISSECTION; MUCOSAL RESECTION; GASTRIC CANCERS; TOOTH LOSS; CARCINOMA; LINXIAN;
D O I
10.1016/j.gie.2011.05.024
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Radiofrequency ablation (RFA) is safe and effective for eradicating neoplasia in Barrett's esophagus. Objective: To evaluate RFA for eradicating early esophageal squamous cell neoplasia (ESCN) defined as moderate-grade squamous intraepithelial neoplasia (MGIN) and high-grade squamous intraepithelial neoplasia (HGIN) and early flat-type esophageal squamous cell carcinoma (ESCC). Design: Prospective cohort study. Setting: Tertiary referral center. Patients: Esophageal unstained lesions (USLs) were identified using Lugol's chromoendoscopy. Inclusion criteria were at least 1 flat (type 0-IIb) USL 3 cm or larger, USL-bearing esophagus 12 cm or less, and a consensus diagnosis of MGIN, HGIN, or ESCC by 2 expert GI pathologists. Exclusion criteria were previous endoscopic resection or ablation, stricture, or any nonflat mucosa. Interventions: Circumferential RFA creating a continuous treatment area (TA) including all USLs. At 3-month intervals thereafter, chromoendoscopy with biopsies followed by focal RFA of USLs, if present. Main Outcome Measurements: Complete response (CR) at 12 months defined as absence of MGIN, HGIN, or ESCC in the TA, CR after 1 RFA session, neoplastic progression from baseline, and adverse events. Results: Twenty-nine patients (14 male, mean age 60.3 years) with MGIN (n = 18), HGIN (n = 10), or ESCC (n = 1) participated. Mean USL length was 6.2 cm (TA 8.2 cm). At 3 months after 1 RFA session, 86% of patients (25/29) had a CR. At 12 months, 97% of patients (28/29) had a CR. There was no neoplastic progression. There were 4 strictures, all dilated to resolution. Limitations: Single-center study with limited number of patients. Conclusions: In patients with early ESCN (MGIN, HGIN, flat-type ESCC), RFA was associated with a high rate of histological complete response (97% of patients), no neoplastic progression, and an acceptable adverse event profile. (Gastrointest Endosc 2011;74:1181-90.)
引用
收藏
页码:1181 / 1190
页数:10
相关论文
共 44 条
  • [1] Prospective study of tooth loss and incident esophageal and gastric cancers in China
    Abnet, CC
    Qiao, YL
    Mark, SD
    Dong, ZW
    Taylor, PR
    Dawsey, SM
    [J]. CANCER CAUSES & CONTROL, 2001, 12 (09) : 847 - 854
  • [2] Tooth Loss and Lack of Regular Oral Hygiene Are Associated with Higher Risk of Esophageal Squamous Cell Carcinoma
    Abnet, Christian C.
    Kamangar, Farin
    Islami, Farhad
    Nasrollahzadeh, Dariush
    Brennan, Paul
    Aghcheli, Karim
    Merat, Shahin
    Pourshams, Akram
    Marjani, Haj Amin
    Ebadati, Abdolhakim
    Sotoudeh, Masoud
    Boffetta, Paolo
    Malekzadeh, Reza
    Dawsey, Sanford M.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (11) : 3062 - 3068
  • [3] [Anonymous], 2007, Global cancer facts and figures 2007
  • [4] Transhiatal versus transthoracic esophagectomy for esophageal cancer
    Barreto, J. Camilo
    Posner, Mitchell C.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (30) : 3804 - 3810
  • [5] Blot W.J., 2006, Cancer Epidemiology and Prevention
  • [6] ARE RACIAL-DIFFERENCES IN SQUAMOUS-CELL ESOPHAGEAL CANCER EXPLAINED BY ALCOHOL AND TOBACCO USE
    BROWN, LM
    HOOVER, RN
    GREENBERG, RS
    SCHOENBERG, JB
    SCHWARTZ, AG
    SWANSON, GM
    LIFF, JM
    SILVERMAN, DT
    HAYES, RB
    POTTERN, LM
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (17) : 1340 - 1345
  • [7] Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114
  • [8] Endoscopic mucosal resection for squamous premalignant and early malignant lesions of the esophagus
    Ciocirlan, M.
    Lapalus, M. G.
    Hervieu, V.
    Souquet, J. C.
    Napoleon, B.
    Scoazec, J. Y.
    Lefort, C.
    Saurin, J. C.
    Ponchon, T.
    [J]. ENDOSCOPY, 2007, 39 (01) : 24 - 29
  • [9] DAWSEY SM, 1994, CANCER, V74, P1686, DOI 10.1002/1097-0142(19940915)74:6<1686::AID-CNCR2820740608>3.0.CO
  • [10] 2-V